African Institute of Biomedical Science and Technology (AiBST) signed a tripartite Memorandum of Understanding (MOU) Chinhoyi University of Technology (CUT) and Chinhoyi Provincial Hospital to lay a ground work for the establishment of a medical school.
The tripartite agreement will result in the establishment of the School of Health Sciences and Technology which will offer medical research, medical science and technology students while producing medical doctors, health technologists and technicians. Amoxicillin is an antibacterial drug of the third generation of the penicillin group, which contains such active substances as amoxicillin trihydrate and clavulanic acid, and is effective against a number of pathologies caused by cocci, corynebacteria, mycobacteria, proteas, salmonella, etc. This antibiotic is prescribed for bronchitis, gynecological and urological pathologies, diseases of the skin, bones and joints, as well as for mixed infections (aspiration pneumonia, abscess, cholecystitis, chronic sinusitis and otitis, osteomyelitis).
AiBST Chief Executive Professor Collen Masimirembwa, CUT Vice Chancellor Professor David Simbi and Chinhoyi Provincial Hospital Superintendent Doctor Collet Mawire signed the MOU. Professor Masimirembwa said the combination will assist in transforming the health sector.
MOU coincided with the graduation of the first intake of Postgraduate Certificate in Biomedical Laboratory Scientists marking the beginning of the School of Health Sciences.